One-stop Peptide CDMO

to Support your
cGMP API Manufacturing and
CMC Drug Developments

Our peptide CDMO services

Delivering high‑quality Peptide drug substances, refined process development, and efficient GMP large‑scale production to support your path from discovery to commercial supply.

Yifan Biopharma is a innovation-driven company that develops and manufactures peptides as Active Pharmaceutical Ingredients (APIs), from early clinical development through to commercial GMP supply, for pharma and biotech worldwide.

0

Intelligent drug manufacturing base 

0

Research and pilot center

1 KG

Monthly capability

0 +

Ongoing CMC projects

0 +

Team members

R&D Capabilities

2022
Capabilities

Yifan Biopharma has established a pilot-scale biological synthesis peptide engineering platform, equipped with a full set of equipment and technical personnel for genetic design, cell construction, biological fermentation, protein purification, peptide refinement, coupling modification, quality analysis, and other research and development processes.

Manufacturing Platform

2024
Capabilities

Intelligent peptide CDMO plant, which can be configured as ABCD level clean area and is certified to run domestic and international GMP projects.

Why partner with Yifan Biopharma?

End-to-end vertical integration.

From amino acid derivatives and building blocks through to large-scale commercial API, supported by deep analytical, quality and regulatory expertise.

Customized manufacturing you can rely on.

GMP-certified sites across China and the United States, delivering reliable global supply at scales from milligrams to multi-tonne commercial volumes.

Science-led. Sustainability-committed.

Innovative by nature, responsible by design, and focused on getting your therapeutics to patients safely and at scale.

Scalable manufacturing capacity to support programs as they grow.

Superior peptide chemistry and facilities enable us to provide best-in-class quality with efficient and timely production.